Abstract
Of 311 colorectal cancers diagnosed in 1984-86 in the county of Ostergotland, Sweden, 179 were included in a case-control study, and, of these, 70 were investigated using immunohistochemical staining for p53 gene mutations. Alcohol use as well as medication with hydralazine-containing antihypertensive drugs, but not heredity were associated with p53 staining. The study is offered to illustrate the possible value of investigating molecularly defined tumour subtypes in relation to specific risk factors.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 24 print issues and online access
$259.00 per year
only $10.79 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Fredrikson, M., Axelson, O., Sun, XF. et al. A pilot study on risk factors and p53 gene expression in colorectal cancer. Br J Cancer 73, 1428–1430 (1996). https://doi.org/10.1038/bjc.1996.271
Issue Date:
DOI: https://doi.org/10.1038/bjc.1996.271
This article is cited by
-
Lower Relative Contribution of Positive Family History to Colorectal Cancer Risk with Increasing Age: A Systematic Review and Meta-Analysis of 9.28 Million Individuals
American Journal of Gastroenterology (2018)
-
Tobacco, alcohol, and p53 overexpression in early colorectal neoplasia
BMC Cancer (2003)